V. Polychronopoulos

1.3k total citations
19 papers, 988 citations indexed

About

V. Polychronopoulos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, V. Polychronopoulos has authored 19 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in V. Polychronopoulos's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). V. Polychronopoulos is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Inhalation and Respiratory Drug Delivery (5 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). V. Polychronopoulos collaborates with scholars based in Greece, United States and United Kingdom. V. Polychronopoulos's co-authors include Demosthenes Bouros, Fotios Drakopanagiotakis, R M du Bois, Andrew Nicholson, Nikolaos M. Siafakas, Charalampos Mermigkis, Maria Dimadi, Κατερίνα Αντωνίου, Anastasia Amfilochiou and A. Rapti and has published in prestigious journals such as Cancer, CHEST Journal and European Respiratory Journal.

In The Last Decade

V. Polychronopoulos

19 papers receiving 957 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Polychronopoulos Greece 14 778 358 109 101 84 19 988
Maria Pieroni Italy 19 736 0.9× 680 1.9× 81 0.7× 78 0.8× 75 0.9× 41 1.1k
Junpei Saito Japan 17 449 0.6× 439 1.2× 75 0.7× 39 0.4× 39 0.5× 65 814
Francesco Cavalli Italy 15 533 0.7× 264 0.7× 103 0.9× 64 0.6× 22 0.3× 46 754
Peter A. Sloane United States 11 522 0.7× 146 0.4× 120 1.1× 65 0.6× 22 0.3× 13 775
Hideki Yasui Japan 21 777 1.0× 366 1.0× 147 1.3× 249 2.5× 50 0.6× 113 1.2k
Kaoru Hamada Japan 18 317 0.4× 312 0.9× 209 1.9× 94 0.9× 43 0.5× 36 952
Yasuo To Japan 18 553 0.7× 566 1.6× 199 1.8× 116 1.1× 24 0.3× 49 1.1k
A Rasidakis Greece 12 401 0.5× 193 0.5× 94 0.9× 135 1.3× 19 0.2× 24 729
Jianmiao Wang China 14 353 0.5× 235 0.7× 179 1.6× 85 0.8× 38 0.5× 40 847
Dionysios Spyratos Greece 14 603 0.8× 178 0.5× 174 1.6× 32 0.3× 46 0.5× 26 932

Countries citing papers authored by V. Polychronopoulos

Since Specialization
Citations

This map shows the geographic impact of V. Polychronopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Polychronopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Polychronopoulos more than expected).

Fields of papers citing papers by V. Polychronopoulos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Polychronopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Polychronopoulos. The network helps show where V. Polychronopoulos may publish in the future.

Co-authorship network of co-authors of V. Polychronopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of V. Polychronopoulos. A scholar is included among the top collaborators of V. Polychronopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Polychronopoulos. V. Polychronopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Kalkanis, Alexandros, Dimitrios Kalkanis, V. Polychronopoulos, & Marc A. Judson. (2013). Detection of sarcoidosis associated fasciitis by uptake on a FDG PET scan: a novel finding.. PubMed. 30(2). 143–5. 3 indexed citations
3.
Papakosta, Despina, Georgia Pitsiou, Zoe Daniil, et al.. (2011). Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters. Lung. 189(5). 391–399. 28 indexed citations
4.
Spyridaki, Aikaterini, Petros Kopterides, Aikaterini Pistiki, et al.. (2011). TREM-1 expression on neutrophils and monocytes of septic patients: relation to the underlying infection and the implicated pathogen. BMC Infectious Diseases. 11(1). 309–309. 14 indexed citations
5.
Mermigkis, Charalampos, Eleni Stagaki, Stavros Τryfon, et al.. (2010). How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis?. Sleep And Breathing. 14(4). 387–390. 104 indexed citations
6.
Karakatsani, Anna, Despoina Papakosta, A. Rapti, et al.. (2009). Epidemiology of interstitial lung diseases in Greece. Respiratory Medicine. 103(8). 1122–1129. 145 indexed citations
7.
Polychronopoulos, V., et al.. (2008). Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer. Cancer. 114(6). 519–526. 18 indexed citations
8.
Katsenos, Stamatis, Charalampos Mermigkis, Kostas Tsintiris, et al.. (2008). Unilateral Lymphocytic Pleuritis as a Manifestation of Familial Mediterranean Fever. CHEST Journal. 133(4). 999–1001. 11 indexed citations
9.
Mermigkis, Charalampos, Eleni Stagaki, Anastasia Amfilochiou, et al.. (2008). Sleep Quality and Associated Daytime Consequences in Patients with Idiopathic Pulmonary Fibrosis. Medical Principles and Practice. 18(1). 10–15. 57 indexed citations
10.
Drakopanagiotakis, Fotios, et al.. (2008). Apoptosis in lung injury and fibrosis. European Respiratory Journal. 32(6). 1631–1638. 136 indexed citations
11.
Mermigkis, Charalampos, Nancy Foldvary‐Schaefer, Joseph A. Golish, et al.. (2007). Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). International Journal of Clinical Practice. 61(2). 207–211. 60 indexed citations
12.
Αντωνίου, Κατερίνα, Andrew G. Nicholson, Maria Dimadi, et al.. (2006). Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis. European Respiratory Journal. 28(3). 496–504. 54 indexed citations
13.
Psathakis, Konstantinos, George Papatheodorou, Stelios Loukides, et al.. (2006). Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. European Journal of Clinical Investigation. 36(5). 362–367. 106 indexed citations
14.
Mermigkis, Charalampos, et al.. (2005). Overexpression of Bcl-2 Protein in Bronchoalveolar Lavage Lymphocytes and Macrophages in Sarcoidosis. Respiration. 73(2). 221–226. 6 indexed citations
15.
Stefanadis, Christodoulos, Christina Chrysohoou, Demosthenes B. Panagiotakos, et al.. (2003). Temperature differences are associated with malignancy on lung lesions: a clinical study. BMC Cancer. 3(1). 1–1. 43 indexed citations
16.
Bouros, Demosthenes, Andrew Nicholson, V. Polychronopoulos, & R M du Bois. (2000). Acute interstitial pneumonia. European Respiratory Journal. 15(2). 412–412. 128 indexed citations
17.
Bouros, Demosthenes, John Kottakis, Pascal Pfister, et al.. (1999). Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma. European Respiratory Journal. 14(3). 627–627. 41 indexed citations
18.
Polychronopoulos, V., et al.. (1999). Theophylline induces a reduction in circulating interleukin-4 and interleukin-5 in atopic asthmatics.. PubMed. 13(1). 53–8. 11 indexed citations
19.
Cooper, Talbert, E J Ladusans, P.E. Williams, et al.. (1985). A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. Journal of Antimicrobial Chemotherapy. 16(3). 373–378. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026